CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Advances in Coronary No-Reflow Phenomenon-a Contemporary Review Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents Multimodality imaging in cardiology: a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging Society of cardiac angiography and interventions: suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial Genotype-Guided Strategy for Oral P2Y12 Inhibitors

Recommandation StatementFeb 13, 2020

JOURNAL:ACC Article Link

ACC Clinical Bulletin Focuses on Cardiac Implications of Coronavirus (COVID-19)

ACC Keywords: COVID-19;

FULL TEXT PDF